Accelerate Time to Market by Leveraging a Manufacturing Partnership
- Key considerations for evaluating potential custom partners
- Examples and lessons learned from Promega Corporation's experience
Advances in life science research are opening up exciting new applications for biotechnology and clinical products. A collaborative partnership with a manufacturing partner can decrease time to market without the investment in manufacturing infrastructure. Additionally, product developers gain insight into product development best practices, work with an experienced partner to ensure quality and regulatory compliance for the product and tap into supply-chain controls and logistical solutions that can result in a competitive advantage. While utilization of a contract manufacturer can result in a variety of benefits, selecting the best manufacturing partner can be a challenge.
Join us for this webinar as we will review key considerations for evaluating potential custom partners, followed by examples and lessons learned from Promega Corporation's experience as a custom manufacturing partner for a variety of markets.
Jason Miller, PhD
Manager, Global Custom & OEM Solutions
Jason Miller leads the Global Custom and OEM Solutions team at Promega Corporation. He received his Ph.D. in Biochemistry at UC, San Diego and his M.B.A. from San Diego State University. During his 12 year tenure at Promega, he has worked with both small businesses and large corporations to bring their products from conceptualization, through development, to manufacturing and commercialization. Currently, his team is comprised of five consultants based throughout the U.S. who manage and support a custom business that accounts for over 20% of Promega’s overall revenue.
Jennifer Romanin, MS
Director, IVD Operations and Global Service and Support
Jennifer is the Director of IVD Operations and Global Service and Support at Promega Corporation. She received a M.S. degree in Manufacturing and Technology Management and a B.S. degree in Bacteriology from the University of Wisconsin-Madison. During the 25 years that Jennifer has been at Promega Corporation, she has held many operations supervisory and managerial roles. In Jen’s current role as Director of IVD Operations and Global Service and Support, she oversees teams that manage and execute the validation program, and manufacture, dispense and package a number of regulated products. She also supervises the Training, Scientific Applications, Field Support Scientists, Instrumentation and Technical Services teams. She represents Promega IVD Operations during customer site visits and leads operational tasks when collaborating with outside partners. Jennifer is also a member of the Global Planning Team, which is tasked with guiding and supporting global facility projects. The team is currently supporting green field facility projects in the United Kingdom, Germany and Wisconsin.
We love to talk science.
Sign up to receive monthly invitations to our webinars.